Breast Carcinoma Amplified Sequence 3 (BCAS3) (N-Term) Peptide
BCAS3
Reactivity: Human
BP
Sodium azide
-
- Target See all BCAS3 products
- BCAS3 (Breast Carcinoma Amplified Sequence 3 (BCAS3))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
18 amino acids near the amino terminus of human BCAS3.
Human
-
- Application Notes
- BCAS3 pepide is used for blocking the activity of BCAS3.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- BCAS3 (Breast Carcinoma Amplified Sequence 3 (BCAS3))
- Synonyms
- GAOB1 Peptide, MAAB Peptide, 1500019F07Rik Peptide, 2610028P08Rik Peptide, AU021018 Peptide, BC028339 Peptide, K20D4 Peptide, rudhira Peptide, RGD1560788 Peptide, zgc:63764 Peptide, BCAS3 Peptide, BCAS3, microtubule associated cell migration factor Peptide, breast carcinoma amplified sequence 3 Peptide, breast carcinoma-amplified sequence 3 Peptide, BCAS3 Peptide, Bcas3 Peptide, bcas3 Peptide, CpipJ_CPIJ009696 Peptide, LOC100540920 Peptide
-
You are here:
